Dimensional Fund Advisors
EPZM

Dimensional Fund Advisors’s Epizyme, Inc EPZM Stock Holding History

Dimensional Fund Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-61,853
Closed -$317K – 3563
2021
Q3 		$317K Sell
61,853
-683,896
-92% -$4.15M ﹤0.01% 3270
2021
Q2 		$6.2M Sell
745,749
-109,597
-13% -$924K ﹤0.01% 2541
2021
Q1 		$7.46M Sell
855,346
-59,769
-7% -$618K ﹤0.01% 2432
2020
Q4 		$9.94M Sell
915,115
-32,689
-3% -$403K ﹤0.01% 2294
2020
Q3 		$11.3M Sell
947,804
-25,011
-3% -$335K ﹤0.01% 2131
2020
Q2 		$15.6M Sell
972,815
-72,023
-7% -$1.26M 0.01% 1993
2020
Q1 		$16.2M Sell
1,044,838
-7,755
-0.7% -$167K 0.01% 1875
2019
Q4 		$25.9M Buy
1,052,593
+213,602
+25% +$3.17M 0.01% 1908
2019
Q3 		$8.65M Buy
838,991
+133,308
+19% +$1.68M ﹤0.01% 2409
2019
Q2 		$8.86M Buy
705,683
+151,746
+27% +$1.95M ﹤0.01% 2434
2019
Q1 		$6.86M Sell
553,937
-2,404
-0.4% -$26.9K ﹤0.01% 2538
2018
Q4 		$3.43M Buy
556,341
+317,157
+133% +$2.42M ﹤0.01% 2714
2018
Q3 		$2.54M Buy
+239,184
New +$2.73M ﹤0.01% 2863
2017
Q2 		– Sell
-65,194
Closed -$1.12M – 3330
2017
Q1 		$1.12M Buy
65,194
+24,807
+61% +$330K ﹤0.01% 2957
2016
Q4 		$489K Buy
40,387
+5,919
+17% +$61.8K ﹤0.01% 3097
2016
Q3 		$339K Buy
+34,468
New +$315K ﹤0.01% 3123

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Dimensional Fund Advisors's EPZM Position: Q4 2021 in Review

Dimensional Fund Advisors sold out of Epizyme, Inc (EPZM) in Q4 2021, closing a stake of 61,853 shares — an estimated $317K sold.

Dimensional Fund Advisors first reported a position in EPZM in Q3 2016 and held it in 16 quarters. The position peaked at $25.9M in Q4 2019. 132 funds tracked by Wall St. Rank hold EPZM as of Q4 2021.

  • Dimensional Fund Advisors reported no remaining Epizyme, Inc position as of Q4 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 61,853 Epizyme, Inc shares in Q4 2021, an estimated $317K.
  • Dimensional Fund Advisors first reported a position in Epizyme, Inc in Q3 2016 and held it in 16 quarters.
  • Dimensional Fund Advisors's Epizyme, Inc position peaked at $25.9M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2021.

Based on Dimensional Fund Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.